The Carlyle Group has agreed to sell Qualicaps (Nara, Japan) to Mitsubishi Chemical Holdings (Tokyo, Japan) subject to regulatory approvals. Qualicaps is a global manufacturer of hard gelatin capsules and non-gelatin cellulose-based capsules, including Quali-V, a pharmaceutical grade vegetarian capsule for the pharma and nutrition industries. According to news reports, Mitsubishi Chemical will pay about $654.2 million for Qualicaps, and estimates that Qualicaps will bring in Â¥19.1 billion in sales in 2012. Carlyle acquired Qualicaps, formerly Shionogi Qualicaps, in October 2005. Its expansion strategy resulted in an increase in revenue and EBITDA of more than 50% and 120% respectively for Qualicaps. Mitsubishi Chemical said in a statement that the capsule market has enjoyed stable single-digit growth in recent years and now has a roughly Â¥100 billion market size. In 2011 Pfizer sold Capsugel, a maker of hard capsules, for $2.38 billion. Capsugel generated approximately $750 million in revenue in 2010.
Disclaimer: NCN does not warrant the accuracy, reliability, or timeliness of any NCN news item. Before relying on any NCN News item the information should be independently verified.
For more finance and investment information, visit Nutrition Capital Network news